Wacker Chemie launched its Wacker Biotechnology Center, a multi-floor facility focused on biopharmaceutical R&D, including protein and nucleic acid production processes essential for mRNA-based therapies. This investment consolidates biotech research capabilities, aiming to accelerate time-to-market for innovative solutions and enhance competitiveness amid economic challenges. The center also explores ingredients for sustainable nutrition, reflecting Wacker's commitment to growth and innovation in biotechnology.